Why were shareholders not informed of previous delays at the...

Why were shareholders not informed of previous delays at the time
19 Nomber they announced Clinical trials on track and shipment of mpl expected end of December - three weeks late trials to commence early May

December 13
GMP manufacturing of mpl progressing well with shipment now expected in January

From memory tablet manufacturing was arranged for first two weeks of February
31 January quarterly timelines
show Syngene manufacturing 10kgs from around 20 January to 13 Feb and Catalent making tablets from start of March to 14 March, this ties into the dates given on 2 February. Where they also stated that manufacturing was to be completed by mid February and that late May 2022 remains the scheduled timing for recruitment for first person into MND clinical trial.
Not early May as stated on 19 November 2021.
How can they state that the manufacturing was progressing well when the completion date just gets push back further and further.
Announcements put out over a number of years are at best misleading and to me it appears the BODs dont have a clue on what is happening.

So now its wait until Mid March and see if tablets actually arrive